FAM
MBIO icon

Fenimore Asset Management’s Mustang Bio MBIO Stock Holding History

Fenimore Asset Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20
Closed -$50K – 119
2021
Q2 		$50K Hold
20
– – ﹤0.01% 125
2021
Q1 		$50K Hold
20
– – ﹤0.01% 119
2020
Q4 		$57K Hold
20
– – ﹤0.01% 112
2020
Q3 		$47K Hold
20
– – ﹤0.01% 107
2020
Q2 		$48K Hold
20
– – ﹤0.01% 107
2020
Q1 		$40K Hold
20
– – ﹤0.01% 112
2019
Q4 		$61K Hold
20
– – ﹤0.01% 113
2019
Q3 		$49K Hold
20
– – ﹤0.01% 119
2019
Q2 		$55K Sell
20
-11
-35% -$31.4K ﹤0.01% 120
2019
Q1 		$78K Sell
31
-20
-39% -$56.7K ﹤0.01% 115
2018
Q4 		$112K Buy
+51
New +$155K ﹤0.01% 117

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fenimore Asset Management's MBIO Position: Q3 2021 in Review

Fenimore Asset Management sold out of Mustang Bio (MBIO) in Q3 2021, closing a stake of 20 shares — an estimated $50K sold.

Fenimore Asset Management first reported a position in MBIO in Q4 2018 and held it in 11 quarters. The position peaked at $112K in Q4 2018. 79 funds tracked by Wall St. Rank hold MBIO as of Q3 2021.

  • Fenimore Asset Management reported no remaining Mustang Bio position as of Q3 2021 after selling out during the quarter.
  • Fenimore Asset Management sold 20 Mustang Bio shares in Q3 2021, an estimated $50K.
  • Fenimore Asset Management first reported a position in Mustang Bio in Q4 2018 and held it in 11 quarters.
  • Fenimore Asset Management's Mustang Bio position peaked at $112K in Q4 2018.
  • 79 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2021.

Based on Fenimore Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.